Statistics for Efficacy and Safety of Doxorubicin-Ifosfamide Versus Gemcitabine-Docetaxel as First-Line Therapy in Advanced Nonuterine Leiomyosarcoma: A Multicenter Real-World Study
Total visits
| views | |
|---|---|
| Efficacy and Safety of Doxorubicin-Ifosfamide Versus Gemcitabine-Docetaxel as First-Line Therapy in Advanced Nonuterine Leiomyosarcoma: A Multicenter Real-World Study | 0 |
Total visits per month
| views | |
|---|---|
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |